218
Participants
Start Date
June 30, 2006
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
Aripiprazole
Tablets, Oral, once daily, 8 weeks
Placebo
Tablets, Oral, once daily, 8 weeks
Seaver And New York Autism Center Of Excellence, New York
Richmond Behavioral Associates, Staten Island
North Shore - Long Island Jewish Health System, Bethpage
Western Psychiatric Institute And Clinic, Pittsburgh
Children'S National Medical Center, Fairfax
Duke Child And Family Study Center, Durham
Mission Hospitals, Asheville
Institute For Behavioral Medicine, Smyrna
University Of Florida, Gainesville
Marsella, Gregory, Boca Raton
University Of South Florida, Tampa
University Of Alabama At Birmingham, Birmingham
Harmonex Neuroscience, Dothan
The Nisonger Center, Columbus
Children'S Hospital Of Michigan, Detroit
Children'S Hospital Of Wisconsin, Milwaukee
Regions Hospital, Saint Paul
University Of Illinois At Chicago, Chicago
Children'S Mercy Hospital, Kansas City
Munroe-Meyer Institute, Omaha
Cutting Edge Research, Oklahoma City
Dallas Pediatric Neurology Associates, Dallas
Bayou City Research, Ltd., Houston
The Children'S Hospital, Aurora
Southwest Autism Research And Resource Center, Phoenix
Clinical Innovations, Inc., Huntington Beach
Stanford University School Of Medicine, Stanford
University Of California-Davis Medical Center, Sacramento
Pacific Institute Of Medical Sciences, Bothell
Cambridge Health Alliance, Medford
Ladders Clinic, Wellsley
Collaborators (1)
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY